Y
Yabao Pharmaceutical Group Co Ltd
SSE:600351
Yabao Pharmaceutical Group Co Ltd
SSE:600351
Price:
6.22
CNY
1.97%
Market Closed
Market Cap:
¥4.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y
|
Yabao Pharmaceutical Group Co Ltd
SSE:600351
|
CN |
|
S
|
StandardAero, Inc.
NYSE:SARO
|
US |
|
Aquaporin A/S
CSE:AQP
|
DK |
Relative Value
The Relative Value of one Yabao Pharmaceutical Group Co Ltd stock under the Base Case scenario is 6.83 CNY. Compared to the current market price of 6.22 CNY, Yabao Pharmaceutical Group Co Ltd is Undervalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
6.83
CNY
Undervaluation 9%
Y
Multiples Across Competitors
Competitors Multiples
Yabao Pharmaceutical Group Co Ltd Competitors
Yabao Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Y
|
Yabao Pharmaceutical Group Co Ltd
SSE:600351
|
4.4B CNY | 1.9 | 19.5 | 14.6 | 14.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
